Select language:  
1800 620 420
Close menu

Harley’s lymphoma tumour shock

Harley and his family stayed in Leukaemia Foundation accommodation during his Burkitt's lymphoma treatment.

  • Non-Hodgkin lymphoma
  • Support services
Read more

Could the immune system hold the key to curing follicular lymphoma?

A world-first research group is investigating a new therapeutic approach.

  • Non-Hodgkin lymphoma
  • Research
Read more
Professor Maher Gandhi

Australian study first ever to use CAR T-cells to prevent relapse after treatment

In a world first, the Australian COMMITTAL trial uses CAR T-cell therapy to improve survival for people with B-cell ALL who have an allogeneic stem cell transplant.

  • Acute lymphoblastic leukaemia
  • Research
  • Treatments and side-effects
Read more
Dr-Ken-Micklethwaite-blood-cancer-australia

Labor’s commitment to blood cancer

The Leukaemia Foundation welcomes Federal Labor’s commitment of $20 million to give Australian blood cancer patients faster access to leading clinical trial drugs and therapies through a new Right to Trial program.

  • Advocacy and policy
Read more

Chloe and family say “Thank you”

Seven-year-old Chloe stayed at our Stirling Cross Village in Perth while undergoing treatment for acute myeloid leukaemia.

  • Acute myeloid leukaemia
Read more
Chloe and her brother at Christmas

Keeping the wheels in motion

Thanks to Holden’s generous support, more than 4500 Australian families are able to get to and from hospital for vital treatment each year – free of charge.

  • Our supporters
  • Support services
Read more
Holden Leukaemia Foundation car with volunteers standing nearby

Go generic for research

There’s now an innovative way for people living with chronic myeloid leukaemia to support vitally needed medical research. 

  • Chronic myeloid leukaemia
  • Research
Read more
Scientist in lab

Q&A with Kimberly Stegmaier

Kimberly Stegmaier's research focuses on finding new therapeutic targets for children with cancer.

  • Acute myeloid leukaemia
  • Research
Read more
Kimberly Stegmaier

After leukaemia: I look at life through different eyes

Richard was affected by skin GVHD after his transplant for AML.

  • Acute myeloid leukaemia
Read more
Richard and Heinke Butt in South America

Improving the “wait and see” approach to treatment for high-risk blood cancer

Researchers have discovered why half of patients with a type of high-risk blood cancer will not respond to a common treatment.

  • Myelodysplastic syndromes
  • Research
Read more
Dr Ashwin Unnikrishnan